Technology
Health
Biotechnology
Alkermes
$24.289876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$24.28
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$1.19 (5.15%) Today
$0.00 (0.00%) As of 4:07 PM EDT after-hours
Why Robinhood?
You can buy or sell Alkermes and other stocks, options, ETFs, and crypto commission-free!
About ALKS
Alkermes Plc IS a biopharmaceutical company, which engages in the development, research, and commercialization of medicines that are designed to address unmet medical needs of patients in major therapeutic areas. Its products include the brands Aristada and Vivitrol. Read More The company was founded on May 4, 2011 and is headquartered in Dublin, Ireland.
Employees
2,300
Headquarters
Dublin, Dublin
Founded
2011
Market Cap
3.62B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
1.36M
High Today
$24.48
Low Today
$23.03
Open Price
$23.06
Volume
1.47M
52 Week High
$46.98
52 Week Low
$21.29
Collections
Technology
Health
Biotechnology
Biopharmaceutical
Medical
Pharmaceutical
Europe (Non-UK)
Europe
ALKS News
Price Paid on Robinhood
47% Lower
Right Now
52 Week Low
$27.54
Average Price Paid
$46.21
52 Week High
$51.70
Analyst Ratings
20%
of 15 ratings
Buy
20%
Hold
53%
Sell
27%
ALKS Earnings
-$0.22
-$0.03
$0.15
$0.34
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Available Jul 25, Pre-Market